Biotech

All Articles

Cullinan, after $25M deal, return bispecific to Harbour

.Cullinan Rehab was impressed sufficient along with Port BioMed's bispecific immune system reactor t...

A better take a look at Fierce Biotech's Brutal 15

.In this particular week's incident of "The Top Pipe," our company're diving in to Intense Biotech's...

Lilly encounters phase 2 failure of tau-targeting med

.The confetti is actually still soaring from Eli Lilly's event celebrating the approval of Alzheimer...

Biogen CMO Maha Radhakrishnan joins Sofinnova-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our summary of substantial management hirings, firings a...

Lykos are going to talk to FDA to reconsider its selection adhering to being rejected of MDMA treatment for trauma

.Complying with a bad revealing for Lykos Therapies' MDMA prospect for trauma at a recent FDA advisi...

AN 2 one-halfs roll call, stops stage 3 trial after records let down

.AN2 Therapeutics is actually reconsidering its own business in feedback to lackluster midphase data...

Merck pays $700M for bispecific, snooping autoimmune opening and also possibility to challenge Amgen in cancer cells

.Merck &amp Co. is paying for $700 million beforehand to challenge Amgen in a blood stream cancer ma...

Gilead pays out J&ampJ $320M to leave licensing deal for seladelpar

.Along With Gilead Sciences about to an FDA decision for its own liver ailment medication seladelpar...

' All palms on deck' at Lilly as peers target being overweight market

.Chief executive officer David Ricks may find the providers setting up outdoors tents at basecamp be...

Entero giving up personnel, abandoning workplace and also stopping R&ampD

.Mattress Liquidators has actually switched Entero Rehabs white as a sheet. The creditor bought Ente...